NeuroInvestment: Neurogenesis Programs Reviewed by NeuroInvestment
4th Oct 2005, 16:57 GMT
CARDIFF, CA (MARKET WIRE) NI Research today announced the release of the October issue of NeuroInvestment, which reviews and evaluates programs devoted to the induction of neurogenesis: accelerating the proliferation and differentiation of the neural stem cells now known to exist in the adult brain. In the field of neuroregeneration, this is the tactical counterpoint to the higher-profile area of stem cell therapy, wherein cells
NeuroInvestment: Neurogenesis Programs Reviewed by NeuroInvestment related news:
- Neurogenesis Programs Reviewed by NeuroInvestment — Neurology News from StratCenter.com
- Trial expert witnesses reviewed — BBC News | UK | World Edition
- "Lotto rapist" case to be reviewed by government — Reuters: Top News
- TiVo killed the radio star? — PVR Wire
- GOP plans cuts in food programs, conservation — MSNBC.com: U.S. News
- A short guide to affiliate programs — The Blog Herald: more blog news more often
- O'Reilly Smartphone Hacks Reviewed — AAS: Series 60 Stories
- ATI Radeon X1800 reviewed — DV Hardware
- Storied programs revive tradition — USATODAY.com College Football - Top Stories
- GOPers Propose Cuts to Food, Conservation Programs — FOXNews.com - Politics
Latest news from Market Wire - Pharmaceuticals and Biotech:
- Qiagen N.V.: QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- IBEX TECHNOLOGIES INC.: IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- Daiichi Sankyo, Inc.: First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Daiichi Sankyo, Inc.: WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
- Targeted Genetics Corporation: Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- Crucell N.V.: Crucell Announces Third Quarter 2006 Results
- Acambis PLC: Acambis PLC announces Update on US MVA procurement
- SkyePharma PLC: SkyePharma PLC announces Board Appointment
- Base Technologies, Inc.: Base Technologies Award of Air Force Surgeon General Contract Continues Rapid Growth Trend
- Eugene Science, Inc.: Eugene Science Signs Major Distribution Agreement With RexGene Biotech